Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 27, 2010 - Issue 9-10
81
Views
5
CrossRef citations to date
0
Altmetric
Research Article

24-HOUR TEMPORAL PATTERN OF NTPDase AND 5′-NUCLEOTIDASE ENZYMES IN RAT BLOOD SERUM

, , , , , , & show all
Pages 1751-1761 | Received 27 Apr 2010, Accepted 21 Jul 2010, Published online: 25 Oct 2010

REFERENCES

  • Agteresch HJ, Dagnelie PC, van den Berg JW, Wilson JH. (1999). Adenosine triphosphate: established and potential clinical applications. Drugs 58:211–232.
  • Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.
  • Burnstock G. (2006a). Historical review: ATP as a neurotransmitter. Trends Pharmacol. Sci. 27:166–176.
  • Burnstock G. (2006b). Purinergic signalling—an overview. Novartis Found. Symp. 276:26–48, 275–281.
  • Burnstock G. (2007). Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 87:659–797.
  • Burnstock G. (2008). Purinergic signalling and disorders of the central nervous system. Nat. Rev. Drug Discov. 7:575–590.
  • Buxton IL, Yokdang N, Matz RM. (2010). Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis. Cancer Lett. 28:131–141.
  • Chagoya de Sánchez V, Hernández-Muñoz R, Díaz-Muñoz M, Villalobos R, Glender W, Vidrio S, Suárez J, Yañez L. (1983). Circadian variations of adenosine level in blood and liver and its possible physiological significance. Life Sci. 33:1057–1064.
  • Chagoya de Sánchez V, Munoz RH, Suarez J, Vidrio S, Yanez L, Aguilar-Roblero R, Oksenberg A, Vega-Gonzalez A, Villalobos L, Rosenthal L, Fernandez-Cancino F., Drucker-Colin R, Diaz-Munoz M. (1996). Temporal variations of adenosine metabolism in human blood. Chronobiol. Int. 13:163–177.
  • Chan KM, Delfert D, Junger KD. (1986). A direct colorimetric assay for Ca2+-stimulated ATPase activity. Anal. Biochem. 157:375–380.
  • Chen-Goodspeed M, Lee CC. (2007). Tumor suppression and circadian function. J. Biol. Rhythms 22:291–298.
  • Duguay D, Cermakian N. (2009). The crosstalk between physiology and circadian clock proteins. Chronbiol. Int. 26:1479–1513.
  • Elliott KJ, Weber ET, Rea MA. (2001). Adenosine A(1) receptors regulate the response of the hamster circadian clock to light. Eur. J. Pharmacol. 414:45–53.
  • Enjyoji K, Sevigny J, Lin Y, Frenette PS, Christie PD, Esch JS, Imai M, Edelberg JM, Rayburn H, Lech M, Beeler DL, Csizmadia E, Wagner DD, Robson SC, Rosenberg RD. (1999). Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat. Med. 5:1010–1017.
  • Erlinge D, Burnstock G. (2008). P2 receptors in cardiovascular regulation and disease. Purinergic Signal 4:1–20.
  • Florio C, Rosati AM, Traversa U, Vertua R. (1991). Circadian-rhythm in adenosine-A1-receptor of mouse cerebral-cortex. Life Sci. 48:PL25–PL29.
  • Frassetto SS, Dias RD, Sarkis JJ. (1993). Characterization of an ATP diphosphohydrolase activity (APYRASE, EC 3.6.1.5) in rat blood platelets. Mol. Cell. Biochem. 129:47–55.
  • Furukoji E, Tanaka N, Yamashita A, Matsumoto M, Fujimura Y, Yamamoto R, Tamura S, Asada Y. (2008). Ecto-nucleoside triphosphate diphosphohydrolase inhibits ATP- and ADP-induced vasoconstriction. Thromb. Res. 121:583–585.
  • Haus E, Smolensky M. (2006). Biological clocks and shift work: circadian dysregulation and potential long-term effects. Cancer Causes Control 17:489–500.
  • Jacobson KA, Gao ZG. (2006). Adenosine receptors as therapeutic targets. Nat. Rev. Drug Dis. 5:247–264.
  • Jin X, Shearman LP, Weaver DR, Zylka MJ, de Vries GJ, Reppert SM. (1999). A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock. Cell 96:57–68.
  • Ko CH, Takahashi JS. (2006). Molecular components of the mammalian circadian clock. Hum. Mol. Genet. 15:R271–R277.
  • Kunapuli SP, Daniel JL. (1998). P2 receptor subtypes in the cardiovascular system. Biochem. J. 336:513–523.
  • Laragh JH, Flier JS, Solomon R, Mitch WE, Williams GH, Epstein FH. (1985). Atrial natriuretic hormone, the renin aldosterone axis, and blood-pressure electrolyte homeostasis. N. Engl. J. Med. 313:1330–1340.
  • Lemmer B. (2006). The importance of circadian rhythms on drug response in hypertension and coronary heart disease—from mice and man. Pharmacol. Ther. 111:629–651.
  • Lévi F, Okyar A, Dulong S, Innominato PF, Clairambault J. (2010). Circadian timing in cancer treatments. Annu. Rev. Pharmacol. Toxicol. 50:377–421.
  • Levy RI. (1984). Causes of the decrease in cardiovascular mortality. Am. J. Cardiol. 54:C7–C13.
  • Mackiewicz M, Nikonova EV, Zimmerman JE, Galante RJ, Zhang L, Cater JR, Geiger JD, Pack AI. (2003). Enzymes of adenosine metabolism in the brain: diurnal rhythm and the effect of sleep deprivation. J. Neurochem. 85:348–357.
  • Maemura K, Takeda N, Nagai R. (2007). Circadian rhythms in the CNS and peripheral clock disorders: role of the biological clock in cardiovascular diseases. J. Pharmacol. Sci. 103:134–138.
  • Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Pinsky DJ, Sesti C, Levi R. (2003). Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases. J. Pharmacol. Exp. Ther. 305:9–16.
  • Mihaylova-Todorova ST, Todorov LD, Westfall DP. (2002). Enzyme kinetics and pharmacological characterization of nucleotidases released from the guinea pig isolated vas deferens during nerve stimulation: evidence for a soluble ecto-nucleoside triphosphate diphosphohydrolase-like ATPase and a soluble ecto-5′-nucleotidase-like AMPase. J. Pharmacol. Exp. Ther. 302:992–1001.
  • Moore-Ede MC. (1986). Physiology of the circadian timing system: predictive versus reactive homeostasis. Am. J. Physiol. 250:R737–R752.
  • Moser M, Penter R, Fruehwirth M, Kenner T. (2006). Why life oscillates—biological rhythms and health. Conf. Proc. IEEE Eng. Med. Biol. Soc. 1:424–428.
  • Murillo-Rodriguez E, Blanco-Centurion C, Gerashchenko D, Salin-Pascual RJ, Shiromani PJ. (2004). The diurnal rhythm of adenosine levels in the basal forebrain of young and old rats. Neuroscience 123:361–370.
  • Oses JP, Cardoso CM, Germano RA, Kirst IB, Rucker B, Furstenau CR, Wink MR, Bonan CD, Battastini AM, Sarkis JJ. (2004). Soluble NTPDase: an additional system of nucleotide hydrolysis in rat blood serum. Life Sci. 74:3275–3284.
  • Pepine CJ. (1991). Therapeutic implications of circadian variations in myocardial ischemia and related physiologic functions. Am. J. Hypertens. 4:p442S–448S.
  • Portaluppi F, Touitou Y, Smolensky M. (2008). Ethical and methodological standards for laboratory and medical biological rhythm research. Chronobiol. Int. 25:999–1016.
  • Reilly DF, Westgate EJ, FitzGerald GA. (2007). Peripheral circadian clocks in the vasculature [review]. Arterioscler. Thromb. Vasc. Biol. 27:1694–705.
  • Reppert SM, Weaver DR. (2002). Coordination of circadian timing in mammals. Nature 418:935–941.
  • Robson SC, Wu Y, Sun XF, Knosalla C, Dwyer K, Enjyoji K. (2005). Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Sem. Thromb. Hemost. 31:217–233.
  • Rolf MG, Brearley CA, Mahaut-Smith MP. (2001). Platelet shape change evoked by selective activation of P2X1 purinoceptors with alpha,beta-methylene ATP. Thromb. Haemost. 85:303–308.
  • Rumjahn SM, Yokdang N, Baldwin KA, Thai J, Buxton ILO. (2009). Purinergic regulation of vascular endothelial growth factor signaling in angiogenesis. Br. J. Cancer 100:1465–1470.
  • Smolensky MH, Peppas NA. (2007). Chronobiology, drug delivery, and chronotherapeutics. Adv. Drug Deliv. Rev. 59:828–851.
  • Todorov LD, Mihaylova-Todorova S, Westfall TD, Sneddon P, Kennedy C, Bjur RA, Westfall DP. (1997). Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature 387:76–79.
  • von Gall C, Garabette ML, Kell CA, Frenzel S, Dehghani F, Schumm-Draeger PM, Weaver DR, Korf HW, Hastings MH, Stehle JH. (2002). Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin. Nat. Neurosci. 5:234–238.
  • Wood PA, Du-Quiton J, You SJ, Hrushesky WJM. (2006). Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol. Cancer Ther. 5:2023–2033.
  • Yang X. (2010). A wheel of time: the circadian clock, nuclear receptors, and physiology. Genes Dev. 24:741–747.
  • Yegutkin GG. (1997). Kinetic analysis of enzymatic hydrolysis of ATP in human and rat blood serum. Biochemistry (Mosc.) 62:619–622.
  • Yegutkin GG. (2008). Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim. Biophys. Acta 1783:673–694.
  • Yegutkin G, Bodin P, Burnstock G. (2000). Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5′-nucleotidase along with endogenous ATP from vascular endothelial cells. Br. J. Pharmacol. 129:921–926.
  • Zimmermann H. (1999). Nucleotides and CD39: principal modulatory players and thrombosis. Nat. Med. 5:987–988.
  • Zimmermann H. (2000). Extracellular metabolism of ATP and other nucleotides. Naunyn. Schmiedebergs Arch. Pharmacol. 362:299–309.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.